NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
Latest Financial Results
Q1 2025
Quarter Ended Mar 31, 2025
Latest Annual Filing
For Fiscal Year Ending Dec 31, 2024
Report Links
Contacts
Corporate
Journey Medical Corporation
9237 East Via De Ventura
Suite 105
Scottsdale, AZ 85258
T: 480-434-6670
contact@jmcderm.com
Investor Relations
Jaclyn Jaffe
T: 781-652-4500
ir@jmcderm.com
Transfer Agent
VStock Transfer
Allison Niccolls
allison@vstocktransfer.com
Email Alerts
Sign up today and receive company updates straight to your inbox.